Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
60.11
-0.50 (-0.82%)
At close: Jun 9, 2026, 4:00 PM EDT
60.63
+0.52 (0.87%)
After-hours: Jun 9, 2026, 4:10 PM EDT
Monopar Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $101 | Buy | Maintains | $101 | +68.03% | Jun 2, 2026 |
| BTIG | BTIG | Buy Maintains $104 | Buy | Maintains | $104 | +73.02% | Jun 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $105 | Buy | Reiterates | $105 | +74.68% | Jun 1, 2026 |
| Lake Street | Lake Street | Buy Maintains $103 | Buy | Maintains | $103 | +71.35% | Jun 1, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $115 | Buy | Maintains | $115 | +91.32% | May 18, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Reiterates $115 | Buy | Reiterates | $115 | +91.32% | May 15, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $109 | Buy | Maintains | $109 | +81.33% | May 15, 2026 |
| Barclays | Barclays | Buy Maintains $125 | Buy | Maintains | $125 | +107.95% | May 15, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.